Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva sells Overland Park business segment - Kansas City Business Journal
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceutical Industries: Latest News, Photos, Videos on Teva Pharmaceutical Industries - NDTV.COM
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
TEVA: Can Teva Pharmaceutical Stock Continue to Rebound in 2021?
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva looks to amp up research collaborations, CEO says
Teva's two new digital inhalers complete Digihaler product line | MobiHealthNews
Teva Pharmaceutical Industries Limited (TEVA) Stock Price, Quote & News - Stock Analysis
Teva Pharmaceuticals will pay $420 million in a federal case
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva follows AbbVie to leave top pharma industry group (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals resolves bribery case with Israel authorities | The FCPA Blog
Teva stock drops after conspiracy allegations on hiking drug prices
